Rheinmetall's CEO Wagers €702,780 of His Own Money While Analysts Trim Their Targets

Armin Theodor Papperger has put his money where his boardroom is. Germany's defense champion disclosed two share purchases by its chief executive — €502,484.40 on Thursday and a further €200,295.60 on Friday, a combined outlay of €702,780 — just as the market was digesting the second guidance cut of the year. The timing is pointed: management confidence on one side of the ledger, deteriorating forecasts on the other.

That contrast frames the real question facing investors. Papperger's buying is a personal vote of faith, but the case for a rebound rests on something harder to manufacture — whether Rheinmetall can convert postponed orders and delayed acceptances into booked revenue, and do it on a credible timetable.

A second cut, and a wider set of causes

Wednesday's downgrade was not the first, and that repetition matters. Rheinmetall now guides to roughly €13.2 billion in sales for 2026, down from a prior range of €13.7–14.2 billion. Profitability took a knock too: the operating margin is now expected at around 18.5%, versus roughly 19% previously.

The company pointed to several distinct pressures rather than a single snag. The order award for the Boxer-based Arminius project is now expected in 2027, artillery ammunition acceptances have slipped, and revenue from newer business lines — notably the collaboration with Destinus — has come in weaker than planned. Associated advance payments and sales shift into 2027 as a result.

Because the causes are spread across separate stages of the pipeline, a single project getting back on track would not be enough to restore confidence. An order award and a lot acceptance are different links in the chain, and either one slipping can keep expected revenue out of the period where it was meant to land.

The growth record is real — and that is the bull case

Against that, the nine-month figures published Thursday make the optimistic reading far from wishful. Revenue for the first nine months of 2026 reached €8.376 billion, up 38% year on year. Operating profit climbed 68% to €1.339 billion, with an operating margin of 16.0%.

That is the foundation on which any recovery thesis sits. If the delays prove to be purely a matter of timing — money moved, not money lost — then a lower full-year guide sits atop a business that is still expanding at a rapid clip. The scenario becomes considerably more persuasive if the deferred revenue eventually arrives and the margin holds as the top line grows.

Papperger's purchases fit that narrative neatly. Their weight as a signal, though, depends on operations confirming the same direction.

The sell side is not waiting for confirmation

Analysts moved quickly. Bernstein Research cut its price target to €1,000 from €1,200 on Friday and downgraded the stock to "Market-Perform" from "Outperform." JPMorgan had already lowered its own target on Thursday while keeping a "Neutral" rating.

The message from both is consistent: a cheaper valuation only becomes justified once the deferred projects show tangible progress and the newer activities deliver their revenue contributions more reliably. Repeated slippage, by contrast, erodes the credibility of the plan itself. Should acceptances slip again or the new business lines miss once more, the schedule would take another hit — and a later Arminius award would resolve only part of the uncertainty.

November 26–27 is the next real test

The near-term catalyst is already circled: Rheinmetall's Capital Markets Day, scheduled for November 26–27, 2026. What investors will be listening for is detail on the timing of project execution and on how the new business activities are developing.

Management's task there is to make the chain legible — from expected order awards through acceptances to eventual revenue recognition. The more convincingly that bridge is built, the stronger the fundamental case for a re-rating. If it stays vague, the execution risk will keep carrying more weight than the growth record, however impressive that record has been. For now, the chief executive has backed his view with his own capital; the company still has to back it with delivery.